SUBSCRIBERS
New vaccine boosts India's bid to become low-cost lab of the world
Published Wed, Mar 11, 2015 · 09:50 PM
New Delhi
INDIA has long been known as a country that knows how to reproduce generic versions of patented drugs at lower cost.
This week it broke new ground when it unveiled the first indigenously developed vaccine against a diarrhoea-causing virus that is one of the leading causes of early childhood deaths around the world.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Jim Beam owner bets on canned vodka cocktails to double revenue
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Cordlife served letter of demand, notice of claim from customers
IndoAgri appoints former EDB chairman Philip Yeo as chairman and lead independent director
GSK profit drops 23% in Q1 on higher costs